Skip to main content
. 2023 Apr 12;14:1183052. doi: 10.3389/fphar.2023.1183052

FIGURE 1.

FIGURE 1

Anticancer efficacy of I13 on CML cells. (A) Structure of I13 and imatinib. (B) The effect of I13 or imatinib on the proliferation of K562, BaF3-WT, and BaF3-T315I cells stimulated with I13 or imatinib (0–20 µM) for 72 h. Error bars represent the SD of the mean.